$1.43
-3.5%Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Total Payments
1
Latest Dividend
$1.7500
Annual Amount
$1.7500
Frequency
Quarterly
| Declaration | Ex-Date | Payment Date | Dividend | Adjusted | Frequency | Growth |
|---|---|---|---|---|---|---|
N/A | Nov 17, 2023 | Dec 6, 2023 | $1.7500 | $1.7500 | Quarterly | - |
Conservative payout with excellent safety margin. Company retains significant earnings for growth, acquisitions, or building cash reserves. Dividend is highly sustainable.
Negative free cash flow while paying dividends is a major red flag. Company burning cash and cannot sustain dividend without external financing.
Strong dividend growth demonstrates management confidence and business strength. Excellent signal for long-term dividend investors.
Sustainable dividend with adequate coverage. Some areas for improvement but overall appears safe for dividend investors.
Growth with sustainability: Strong dividend increases coupled with conservative payout ratios suggest robust business momentum and shareholder-friendly management committed to value creation.
Continue your LITS research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.